These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 29960015)

  • 1. A doxorubicin loaded colloidal delivery system for the intravesical therapy of non-muscle invasive bladder cancer using wheat germ agglutinin as targeter.
    Apfelthaler C; Skoll K; Ciola R; Gabor F; Wirth M
    Eur J Pharm Biopharm; 2018 Sep; 130():177-184. PubMed ID: 29960015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poly - (l) - glutamic acid drug delivery system for the intravesical therapy of bladder cancer using WGA as targeting moiety.
    Apfelthaler C; Anzengruber M; Gabor F; Wirth M
    Eur J Pharm Biopharm; 2017 Jun; 115():131-139. PubMed ID: 28237713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A lectin mediated delivery system for the intravesical treatment of bladder diseases using poly-(L)-glutamic acid as polymeric backbone.
    Apfelthaler C; Gassenbauer P; Weisse S; Gabor F; Wirth M
    Eur J Pharm Sci; 2018 Jan; 111():376-382. PubMed ID: 29030178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UPEC biomimickry at the urothelial barrier: lectin-functionalized PLGA microparticles for improved intravesical chemotherapy.
    Neutsch L; Wambacher M; Wirth EM; Spijker S; Kählig H; Wirth M; Gabor F
    Int J Pharm; 2013 Jun; 450(1-2):163-76. PubMed ID: 23628404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. c(RGDfK) decorated micellar drug delivery system for intravesical instilled chemotherapy of superficial bladder cancer.
    Zhou D; Zhang G; Gan Z
    J Control Release; 2013 Aug; 169(3):204-10. PubMed ID: 23388072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lectin-mediated drug targeting: preparation, binding characteristics, and antiproliferative activity of wheat germ agglutinin conjugated doxorubicin on Caco-2 cells.
    Wirth M; Fuchs A; Wolf M; Ertl B; Gabor F
    Pharm Res; 1998 Jul; 15(7):1031-7. PubMed ID: 9688056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Penetration of intravesical doxorubicin in human bladders.
    Wientjes MG; Badalament RA; Au JL
    Cancer Chemother Pharmacol; 1996; 37(6):539-46. PubMed ID: 8612307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug delivery system based on dendritic nanoparticles for enhancement of intravesical instillation.
    Qiu X; Cao K; Lin T; Chen W; Yuan A; Wu J; Hu Y; Guo H
    Int J Nanomedicine; 2017; 12():7365-7374. PubMed ID: 29066888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycan-mediated uptake in urothelial primary cells: Perspectives for improved intravesical drug delivery in urinary tract infections.
    Pichl CM; Feilhauer S; Schwaigerlehner RM; Gabor F; Wirth M; Neutsch L
    Int J Pharm; 2015 Nov; 495(2):710-8. PubMed ID: 26383837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cationic core-shell nanoparticles for intravesical chemotherapy in tumor-induced rat model: safety and efficacy.
    Erdogar N; İskit AB; Eroglu H; Sargon MF; Mungan NA; Bilensoy E
    Int J Pharm; 2014 Aug; 471(1-2):1-9. PubMed ID: 24836669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravesical epirubicin versus doxorubicin for superficial bladder tumors (stages pTa and pT1): a randomized prospective study.
    Ali-el-Dein B; el-Baz M; Aly AN; Shamaa S; Ashamallah A
    J Urol; 1997 Jul; 158(1):68-73; discussion 73-4. PubMed ID: 9186325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lectin bioconjugates trigger urothelial cytoinvasion--a glycotargeted approach for improved intravesical drug delivery.
    Neutsch L; Eggenreich B; Herwig E; Marchetti-Deschmann M; Allmaier G; Gabor F; Wirth M
    Eur J Pharm Biopharm; 2012 Oct; 82(2):367-75. PubMed ID: 22889683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LogP of N-acyl-gemcitabine and lectin-corona emerge as key parameters in nanoparticulate intravesical cancer therapy.
    Anzengruber M; Wimmer L; Szuchar R; Skoll K; Wirth M; Gabor F
    Eur J Pharm Sci; 2023 Jan; 180():106330. PubMed ID: 36379358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poly(amidoamine)-modified mesoporous silica nanoparticles as a mucoadhesive drug delivery system for potential bladder cancer therapy.
    Wang B; Zhang K; Wang J; Zhao R; Zhang Q; Kong X
    Colloids Surf B Biointerfaces; 2020 May; 189():110832. PubMed ID: 32070865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Value of European Organisation for Research and Treatment of Cancer score system for predication of immediate postoperative intravesical instillation of pirarubicin after transurethral resection of non-muscle invasive bladder cancer].
    Ding XL; Yang DL; Yan RP; Li ZP; Ye CW; He J; Yu L; He SC; Li HD
    Zhonghua Zhong Liu Za Zhi; 2018 Apr; 40(4):308-312. PubMed ID: 29730921
    [No Abstract]   [Full Text] [Related]  

  • 16. Sustained prophylactic effect of intravesical bacille Calmette-Guérin for superficial bladder cancer: a smoothed hazard analysis in a randomized prospective study.
    Hinotsu S; Akaza H; Isaka S; Kanetake H; Kubota Y; Kuroda M; Shinohara N; Shinka T; Tachibana M; Naito S; Hirao Y;
    Urology; 2006 Mar; 67(3):545-9. PubMed ID: 16527576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DPPG
    van Valenberg FJP; Brummelhuis ISG; Lindner LH; Kuhnle F; Wedmann B; Schweizer P; Hossann M; Witjes JA; Oosterwijk E
    Int J Nanomedicine; 2021; 16():75-88. PubMed ID: 33447028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomimetic delivery strategies at the urothelium: targeted cytoinvasion in bladder cancer cells via lectin bioconjugates.
    Neutsch L; Eggenreich B; Herwig E; Marchetti-Deschmann M; Allmaier G; Gabor F; Wirth M
    Pharm Res; 2014 Mar; 31(3):819-32. PubMed ID: 24366662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-delivery of peptide-modified cisplatin and doxorubicin via mucoadhesive nanocapsules for potential synergistic intravesical chemotherapy of non-muscle-invasive bladder cancer.
    Lu S; Xu L; Kang ET; Mahendran R; Chiong E; Neoh KG
    Eur J Pharm Sci; 2016 Mar; 84():103-15. PubMed ID: 26780592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional chemotherapy using continuous intravesical infusion doxorubicin for the treatment of muscle invasive transitional cell bladder carcinoma in a rat model.
    See WA; Xia Q; McDermott T; Williams RD
    J Urol; 1991 Oct; 146(4):1147-52. PubMed ID: 1895443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.